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Accepted 17 October 2014; Published online 2 December 2014AbstractObjectives: In comparative systematic reviews of diagnostic accuracy, inconsistencies between direct and indirect comparisons may
lead to bias. We investigated whether using individual patient data (IPD) can adjust for this form of bias.
Study Design and Setting: We included IPD of 3 ovarian reserve tests from 32 studies. Inconsistency was defined as a statistically
significant difference in relative accuracy or different comparative results between the direct and indirect evidence. We adjusted for the
effect of threshold and reference standard, as well as for patient-specific variables.
Results: Anti-M€ullerian hormone (AMH) and follicle stimulation hormone (FSH) differed significantly in sensitivity (0.1563,
P 5 0.04). AMH and antral follicle count (AFC) differed significantly in sensitivity (0.1465, P ! 0.01). AMH and AFC differed signif-
icantly in specificity (0.0607, P 5 0.02). The area under the curve (AUC) differed significantly between AFC and FSH (0.0948,
P ! 0.01) in the direct comparison but not (0.0678, P 5 0.09) in the indirect comparison. The AUCs of AFC and AMH differed signif-
icantly (0.0830, P! 0.01) in the indirect comparison but not (0.0176, P 5 0.29) in the direct comparison. These differences remained
after adjusting for indirectness.
Conclusion: Estimates of comparative accuracy obtained through indirect comparisons are not always consistent with those obtained
through direct comparisons. Using IPD to adjust for indirectness did not successfully remove the bias in this case study.  2015 Elsevier
Inc. All rights reserved.
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alized estimating equation1. Introduction
Studies of test accuracy evaluate how well a test is able
to identify patients with the target condition, or target
event, by comparing test results against the reference stan-
dard. Systematic reviews of test accuracy studies try to
obtain more precise summary estimates of the accuracy
and to explore sources of variability in accuracy. Some re-
views target not just one medical test but two or more and
evaluate whether the accuracy of one test is better than thatConflict of interest: None.
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0895-4356/ 2015 Elsevier Inc. All rights reserved.of another one. In such comparative systematic reviews,
one can include direct and indirect test comparisons. Direct
comparisons, also known as head-to-head comparisons,
evaluate two or more tests in the same study, preferably
in the same patients. Indirect comparisons refer to data
from separate studies: one test is evaluated in a series of
studies, whereas the second test is evaluated in different
studies and different patients.
For various reasons, for example, different test settings,
different patients, indirect comparisons are more prone to
bias than direct comparisons, and one may be tempted to
restrict comparative reviews to direct comparisons [1]. On
the other hand, excluding indirect comparisons in system-
atic reviews may lead to a loss in precision in the summary
estimates and fewer data to explore heterogeneity.
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Key findings
 Comparative results of test accuracy obtained
through indirect comparisons are not always
consistent with those obtained through direct com-
parisons. Even with individual patient data (IPD),
there is no generally applicable way to make re-
sults of indirect comparisons more comparable to
results of direct comparisons.
What this add to what was known?
 All previous studies on indirectness in comparative
systematic review were based on study-level data.
This is the first time IPD is used to investigate
and adjust for indirectness.
What is the implication and what should change
now?
 It is difficult to get unbiased estimates from indi-
rect comparisons, even if with adjustment on IPD
level. A comparative study design in diagnostic test
accuracy studies can make the comparisons more
reliable.
Inconsistency in the treatment effects between direct and
indirect comparisons has previously been observed in
systematic reviews of competing interventions [2]. This
finding also applies to systematic reviews of diagnostic test
accuracy. Takwoingi et al. [3] compared results from direct
and indirect comparisons of diagnostic tests in 36 reviews
and found that indirect comparisons do give different re-
sults than direct comparisons and the direction of the bias
cannot be predicted.
Ways to correct for indirectness were investigated by
several researchers. Leeflang et al. analyzed 17 compari-
sons between assays for D-dimer testing and found a sig-
nificant effect of indirectness in five of them. To make
results from indirect comparisons in correspondence with
results from direct comparisons, they used a bivariate
random-effects meta-regression model with assay-type
and directness as covariates and included study features
to correct for the effect of indirectness on sensitivity or
specificity. The results in the study by Leeflang et al. [4]
showed that adjusting for study features did not have much
effect on removing the indirectness. So, it is still doubtful
whether and how direct and indirect comparisons in sys-
tematic reviews and meta-analysis of test accuracy studies
can be combined successfully, that is, without introducing
bias.
All previous studies were based on aggregated data at
study level, which vary with the threshold for test positivity,
the clinical reference standard, and the target population.This information can often be obtained from primary
studies. An advanced approach to summarizing the evi-
dence from primary studies is to acquire the original data
from included studies and to perform statistical analyses
at the individual patient data (IPD) level. IPD meta-
analysis offers the possibility of performing additional
types of analyses, such as reconciling thresholds and refer-
ence standards from primary studies to the same value, ad-
justing for baseline differences in study-level as well as
patient-level characteristics, and using continuous results
instead of dichotomized cutoff values [5].
The objective of this case study was to investigate
whether using IPD from primary studies can overcome
the limitations in analyses based on study-level data. We
explored how we can adjust for indirectness with IPD
meta-analysis and developed and evaluated methods for ad-
justing the indirect comparisons, so that the results from
such comparisons are more consistent with those from
direct comparisons.2. Data
2.1. Data acquisition
This IPD case study was facilitated by the EXPORT data
set used in the ‘‘Excessive Response Prediction using
Ovarian Reserve Tests’’ project, a collaborative IPD
meta-analysis comparing the accuracy of anti-M€ullerian
hormone (AMH), antral follicle count (AFC), and follicle
stimulation hormone (FSH) in predicting poor ovarian
response in in vitro fertilization (IVF) [6]. The data set con-
tained 34 databases including 6,852 women undergoing
IVF.
These ovarian reserve tests (ORT) were initially sug-
gested to have a good predictive value for pregnancy, but
recent studies showed that these tests are more effective
in predicting the ovarian response [7]. AMH, AFC, and
FSH are three most widely used ORTs frequently used
before IVF treatment to predict poor response to ovarian
stimulation [8].
Patient characteristics, such as age, body mass index
(BMI), or duration of subfertility, not only have a strong
predictive power for ovarian response but also influence
the inherent discriminatory accuracy of the ORTs [6].
These variables can help in finding out whether the differ-
ence in baseline characteristics is the source of bias in indi-
rect comparisons and provide us the probability to adjust
for indirectness by including covariates.
Comparisons were limited to pairs of tests, which are the
simplest and most common cases of test comparison. So
from the data set, we can generate three pairwise compari-
sons between two tests: AMH vs. FSH, AMH vs. AFC,
FSH vs. AFC, which could make best use of the IPD data
set and provide more evidence to evaluate the usefulness
of the adjustments. In each pairwise comparison, a direct
comparison was defined as a study in which patients had
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one in which patients had undergone only one of the two
tests.2.2. Dichotomous tests and continuous tests
Some diagnostic tests have only two possible results,
classified as positive and negative, and such tests are termed
dichotomous tests. Other tests with continuous results are
termed continuous tests and may provide useful clinical in-
formation over a wide range of values. Diagnostic accuracy
of dichotomous tests can be expressed in sensitivity and
specificity, likelihood ratios, and diagnostic odds ratio,
whereas the discriminatory power of continuous tests is
usually measured with the area under a receiver operator
characteristic (ROC) curve [9].
Many test results are continuous in nature but classified
as positive and negative; thus, in most of the diagnostic test
accuracy (DTA) studies, data are generally reported in a
dichotomous way, that is, in 2  2 tables. This common
and simple way of reporting provides reduced information
for meta-analyses and neglects the potential diagnostic in-
formation contained in continuous test results. Different
formats of reporting in primary studies will lead to different
statistical methods implemented in data analysis. So, the
three ORTs are treated as both dichotomous tests and
continuous tests, which will be discussed separately in
following sections.3. Methods
There are two main sources of bias in indirect compari-
sons: heterogeneity between studies, which may be from
different reference standards or thresholds in primary
studies, and differences in baseline characteristics, which
may lead to confounding and effect modification. We pro-
pose two corresponding types of adjustments with IPD.
One focuses on the comparability of test results from
different studies (type I) and the second on covariate effect
(type II). The two adjustments are on different layers: only
test results (index tests, reference standard, or both) are
needed for type I adjustment, which are the essential infor-
mation from the primary studies; more information, for
example, patient characteristics, are needed for type II
adjustment. These two types of adjustments could be per-
formed individually or together. When there are no suffi-
cient patient-level data containing patient characteristics,
thus type II adjustment is not feasible, we can use only type
I adjustment and vice versa. But it is highly recommended
to perform type I adjustment all the time as the first step
when it is possible because adjustment on test results can
influence the estimate of test accuracy directly. So, in the
analyses of this case study, type I adjustment was imple-
mented in analysis 1 and type I þ type II adjustments were
implemented in analysis 2.3.1. Type I adjustment: adjustment of reference
standard and test results
In meta-analysis of DTA studies, the included primary
studies may use different reference standards or use the
same reference standard but with different cutoff values
to define diseased and nondiseased patients. This difference
may lead to heterogeneity in test accuracy. IPD provides the
opportunity to redefine the disease status of all patients if
individual-level information about the reference standard
was reported in the data set. So by adjusting reference stan-
dard, we can make sure that test accuracies in different pri-
mary studies are measured against the same reference
standard and the same cutoff point.
Besides the reference standard, the definition of the pos-
itivity of index tests may also vary among studies and the
differences in sensitivity and specificity between studies
may result from the use of different threshold levels [10].
To make the pooling of data from primary studies more
comparable, for each index test, a single cutoff value should
be defined and applied to all the patients in all studies. The
general cutoff point of index test can be obtained by maxi-
mizing overall accuracy or minimizing the total cost of
misclassification, and this value should be reasonable and
in the range of cutoffs reported in the primary studies.
For continuous tests, there are no cutoffs, but test results
can differ between primary studies both in controls and
cases. Janes and Pepe [11] proposed a model to correct
for the heterogeneity, by standardizing the test results for
differences in the test result levels in controls between
studies. They use the distribution of continuous test results
in the control population as a reference distribution and
calculate ‘‘percentile value’’ by standardizing the test re-
sults in the case population. Percentile values do not have
measurement units and take values between 0 and 1; thus,
systematic differences in index test results can be removed
by using percentile value instead of original value. In our
analysis, percentile values will be used in ROC analysis
and calculation of AUC.3.2. Type II adjustment: adjustment of covariate effect
We can alternatively perform covariate adjustment with
patient characteristics that may influence the test accuracy.
We can call this kind of adjustments as type II adjustments.
When there are covariates associated with both test re-
sults and disease status, test accuracy may be overestimated
or underestimated if these confounders are not considered
in the design of diagnostic accuracy studies [12]. In direct
comparisons, all the tests are evaluated based on the same
patient population, so the comparison is less affected by
these covariates, but in indirect comparisons, tests are eval-
uated in different patient groups, which may have different
level of confounders, for example, age distribution. Thus,
comparative results may be distorted in indirect compari-
sons. Regression models can be used for exploration of
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and specificity) by including covariates [13]. However,
maybe due to the lack of a universal method for adjusting
for covariates, controlling for confounding has been rarely
used by clinical investigators in the context of diagnostic
studies [12].
We first consider dichotomous tests. In systematic re-
views of dichotomous tests, meta-analysis of sensitivity
and specificity values is preferred over meta-analysis of
likelihood ratios [14], so we compare dichotomous tests by
their sensitivities and specificities. Pooling of sensitivity
and specificity separately is not recommended because
the paired nature of sensitivities and specificities from
individual studies is ignored. A robust and commonly used
approach is the construction of a summary receiver oper-
ating characteristic curve, which considers the underlying
relationship between sensitivity and specificity. However,
in this IPD meta-analysis, we combined data but not esti-
mates from individual studies, and sensitivity and specificity
were defined on a per-observation basis, so they can be
analyzed separately.
When comparing two tests, some patients provide data
for only one test; test results from a single patient who took
two tests are correlated. A marginal regression model
framework proposed by Leisenring et al. [13] allows
comparing diagnostic tests with unbalanced data, which
contain both paired data (direct comparison) and unpaired
data (indirect comparison), and generalizes McNemar’s test
for paired binary data.
In this study, we have patient characteristics such as age,
BMI level, and duration of subfertility as covariates for
type II adjustment. The parameter estimation was imple-
mented with generalized estimating equations (GEE) with
exchangeable correlation structure. By comparing parame-
ters from a model including these covariates with parame-
ters of the basic model without covariates, we can
investigate whether covariate adjustment is a way to correct
for indirectness.
For continuous tests, AUC was used as a measure of test
accuracy. Janes and Pepe [11] showed that when confound-
ing was present, the overall ROC curve and AUC substan-
tially differed from stratum-specific ROC curve and AUC.
Thus, they suggested that methods for covariate adjustment
are needed in ROC analysis. In this study, adjusting for co-
variate effect is implemented with covariate-adjusted ROC
(AROC) curve [15,16]. With this model, covariates that
may influence the test accuracy could be statistically
adjusted in the ROC analysis.Table 1. Number of patients in each pairwise comparison
Comparisons
FSH vs. AFC AMH vs. AFC FSH vs. AMH
FSH AFC AMH AFC FSH AMH
Direct comparison 2,248 1,024 1,747
Indirect comparison 2,108 252 867 1,476 2,609 144
Abbreviations: FSH, follicle stimulation hormone; AFC, antral fol-
licle count; AMH, anti-M€ullerian hormone.3.3. Comparing diagnostic test accuracy in direct and
indirect comparisons
For dichotomous tests, we include binary variable Z that
indicates indirectness in comparison and the interaction






50), where b3 is the parameter of the interactionterm in formula 1 (or formula 2) (see Appendix A at
www.jclinepi.com), is equivalent to a statement that there
is no difference between direct and indirect comparisons
of test sensitivity (1  specificity).
For continuous tests, in each pair of comparisons, AUCs
of each test were estimated with empirical (nonparametric)
method in direct comparison and indirect comparison sepa-
rately and compared with DeLong’s test for two correlated
ROC curves in paired data (direct comparisons) and its
extension for unpaired ROC curves in indirect comparisons
[17]. In type II adjustments, AROC was used as the mea-
sure of accuracy instead of AUC. Then, we can see whether
there are inconsistencies between comparative results from
direct and indirect comparisons.4. Results
4.1. Data set
The final data set only included women who provided
information about ovarian response, in terms of number
of oocytes, who had taken at least one of the three ORTs.
As a result, 4,762 women from 32 databases were suitable
for the analysis of tests comparison, in which 1,001
(21.0%) women had a poor response. Table 1 lists the num-
ber of patients in each pairwise comparison separated by
the type of comparisons.
4.2. Reference standard
Different cutoff points were used in primary studies to
define ‘‘poor response.’’ Because in our IPD data set, every
study reported the exact number of oocytes for each indi-
vidual patient, we defined poor response for all individual
patients according to a single and commonly used defini-
tion: the yield of four or less oocytes at follicle [18].
4.3. Dichotomous tests
In this study, we defined the single cutoff value for each
ORT in all studies by maximizing the Youden’s index [19]
(sensitivity þ specificity  1) based on the data set and
consulting with recently published systematic reviews of
each ORT [20e22]. We know that using Youden’s index
is debatable, but this way we have an objective and uniform
method for selecting a cutoff. AMH test results less than
1.28 ng/mL were defined as positive; AFC number less than
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larger than or equal to 7.72 IU/L were defined as positive.
These values are all in the range of cutoffs reported in the
systematic reviews of these ORTs [20e22].
Comparisons between the tests sensitivities are based on
the marginal regression model in formula 1 (see Appendix
A at www.jclinepi.com), where Z 5 1 for indirect compar-
isons and Z 5 0 for direct comparisons, XZ is the interac-
tion term of test type and indirectness. A similar model
(formula 2, Appendix A at www.jclinepi.com) is imple-
mented for 1  specificity. Analysis 1 represents compara-
tive results from data adjusted for reference standard and
threshold effect (type I adjustment), and analysis 2 repre-
sents comparative results after adjusting for covariate effect
in addition to analysis 1 (type I þ type II adjustments).
Both results are shown in Table 2.
Table 2 lists the parameter estimates and 95% confidence
intervals (in parentheses). For sensitivity, the differences be-
tween AMH vs. FSH (0.1563, P 5 0.04) and AMH vs.
AFC (0.1465, P ! 0.01) in direct and indirect comparisons
are significant. For specificities, the difference between
AMH vs. AFC (0.0607, P 5 0.02) in direct and indirect
comparisons is significant. Thus, after applying the same
reference standard and thresholds to all primary studies,
inconsistency between direct and indirect comparisons is still
observed. This means that in this case, with type I adjust-
ment only, we cannot always remove the bias of indirectness.
We further adjusted the models by including the
following covariates in the regression models for sensitivityTable 2. Regression coefficients for analyses of sensitivity and 1  specific
Comparisons
Sensitivity
Analysis 1 Analysis 2
AMH vs. FSH
b0 Intercept 0.4277 (0.2388, 0.6166) 1.2196 (2.3203, 0
b1 Test type 0.7898 (0.5422, 1.0374) 3.3739 (5.2030, 1
b2 Indirectness 0.1661 (0.4321, 0.0999) 0.2127 (0.4832, 0.0
b3 Test type 3
indirectness
L0.7491 (L1.4489, L0.0492) L0.9264 (L1.6251, L0
b4 Age 0.0453 (0.0151, 0.07
b5 Test type  age 0.1177 (0.0656, 0.16
AMH vs. AFC
b0 Intercept 0.8755 (0.5965, 1.1545) 4.7563 (6.3721, 3
b1 Test type 0.0202 (0.3079, 0.2676) 0.1319 (1.8282, 2.0
b2 Indirectness 0.1940 (0.5751, 0.1870) 0.3086 (0.7147, 0.0
b3 Test type 3
indirectness
0.7650 (0.2675, 1.2625) 0.8967 (0.3619, 1.431
b4 Age 0.1573 (0.1125, 0.20
b5 Test type  age 0.0044 (0.0604, 0.0
FSH vs. AFC
b0 Intercept 0.7563 (0.5540, 0.9587) 5.1348 (6.8609, 3
b1 Test type 0.5519 (0.7970, 0.3069) 3.5902 (1.7434, 5.43
b2 Indirectness 0.1375 (0.4473, 0.7223) 0.4413 (0.1497, 1.0
b3 Test type 3
indirectness
0.1360 (0.4936, 0.7651) 0.1561 (0.7910, 0.4
b4 Age 0.1617 (0.1147, 0.20
b5 Test type  age 0.1144 (0.1648, 0
Abbreviations: AMH, anti-M€ullerian hormone; FSH, follicle stimulation
Numbers in parentheses are 95% confidence intervals of parameter estim
are in bold.(1  specificity): age and accordingly the interaction term
of age and test type (analysis 2). After type II adjustment,
the parameter b3, which indicates the differences in sensi-
tivities or specificities, is still significant. The results we
got from analysis 2 showed that the inclusion of patient
characteristic had no influence on those comparisons, and
with type II adjustment, we cannot remove the bias of indi-
rectness either.4.4. Continuous tests
The ROC curves and AUCs after adjusting for reference
standard and standardizing the test results (type I adjust-
ments) are shown in Fig. 1 and Table 3. In the first pair, both
direct comparisons and indirect comparisons gave the same
conclusion: AMH had a better performance than FSH, but
the discriminatory power of both tests in direct comparisons
was higher than in indirect comparisons. In the second pair,
the difference in AUCs between AFC and FSH (0.0948,
P! 0.01) is significant in direct comparisons but not signif-
icant (0.0678, P 5 0.09) in indirect comparisons. It was
observed that AFC performed much better when directly
compared with FSH. In the third pair, the difference between
AFC and AMH is significant (0.0830, P ! 0.01) in indi-
rect comparison but not significant (0.0176, P 5 0.29) in
direct comparison. This is because of the increase from
0.78 to 0.83 in the AUC of AMH and the drop from 0.76
to 0.75 in the AUC of AFC in the indirect comparison.
The inconsistencies were observed after type I adjustments.ity
1 L Specificity
Analysis 1 Analysis 2
.1188) 1.0660 (1.1907, 0.9412) 3.7703 (4.3701, 3.1705)
.5448) 0.0827 (0.2447, 0.0794) 3.5339 (4.7672, 2.3007)
579) 0.2819 (0.1276, 0.4363) 0.1465 (0.0134, 0.3064)
.2277) 0.0362 (0.4993, 0.4270) 0.2241 (0.6698, 0.2217)
54) 0.0811 (0.0636, 0.0986)
99) 0.1006 (0.0656, 0.1357)
.1404) 1.1363 (1.2993, 0.9733) 5.4416 (6.2868, 4.5965)
919) 0.1891 (0.3669, 0.0112) 1.8664 (3.0744, 0.6583)
975) 0.0937 (0.1135, 0.3009) 0.0231 (0.2376, 0.1914)
6) 0.3279 (0.0477, 0.6080) 0.3419 (0.0445, 0.6393)
22) 0.1289 (0.1047, 0.1531)
517) 0.0485 (0.0141, 0.0828)
.4088) 1.1552 (1.2630, 1.0474) 5.3853 (6.2536, 4.5171)
70) 0.0182 (0.1589, 0.1224) 1.5623 (0.5567, 2.5678)
323) 0.7057 (0.3948, 1.0166) 0.7387 (0.4166, 1.0608)
788) 0.1354 (0.4746, 0.2038) 0.2599 (0.6127, 0.0928)
87) 0.1246 (0.0998, 0.1493)
.0640) 0.0460 (0.0748, 0.0173)
hormone; AFC, antral follicle count.
ates; significant differences between direct and indirect comparisons
Fig. 1. ROC curves of pairwise comparisons in direct and indirect comparisons after adjustment for heterogeneity.
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adjusting for covariates (type II adjustments) in addition to
type I adjustments. The inconsistencies between direct and
indirect comparisons still existed after type II adjustments,
in which we tried to adjust for indirectness by considering
covariate effect.5. Discussion
In this IPD case study, we proposed two types of adjust-
ments to correct for the effect of indirectness in comparative
systematic reviews of DTA studies. Type I adjustments were
focused on threshold effect and reference standard issues,
whereas type II adjustments additionally focused on patient
characteristics. These adjustments were not successful in
removing the bias from indirectness in the present case
study: differences between direct and indirect comparisons
persisted, even after applying these adjustments.
Analyses were performed with both dichotomous tests
and continuous tests. Because most of the DTA studiesreport dichotomized test results, ORT results were firstly
treated as dichotomous tests and compared by their sensi-
tivities and specificities using the generalized McNemar’s
score test. The bias was defined as the difference in relative
accuracy between direct and indirect comparisons and
tested by the significance of the parameter in a GEE model.
It is a very intuitive and powerful way to detect the differ-
ence between direct and indirect comparisons. In the three
pairs of comparisons, two pairs showed a significant effect
of indirectness on sensitivity and/or specificity both after
type I and type II adjustments.
If we keep the continuous nature of ORT data and
compare ROC curves generated from direct and indirect
comparisons, we also observed these inconsistencies.
Although the difference in the second pair (AFC vs.
FSH) may attribute to the stronger power of the statistical
test used in paired data, because small difference in AUCs
can be significant if they are strongly correlated, the differ-
ence in the third pair (AFC vs. AMH) confirmed our
finding. Neither type I nor type II adjustments can remove
the bias of indirectness successfully.
Table 3. Comparisons of AUCs in each pairwise comparison
AMH vs. FSH AMH FSH Difference P-value
Direct comparison 0.8135 (0.79, 0.84) 0.6888 (0.66, 0.72) 0.1247 !0.001
Indirect comparison 0.7434 (0.65, 0.84) 0.6280 (0.60, 0.66) 0.1154 0.0246
AFC vs. FSH AFC FSH Difference P-value
Direct comparison 0.7606 (0.74, 0.79) 0.6658 (0.63, 0.70) 0.0948 !0.001
Indirect comparison 0.7202 (0.65, 0.79) 0.6524 (0.62, 0.68) 0.0678 0.0925
AFC vs. AMH AFC AMH Difference P-value
Direct comparison 0.7648 (0.73, 0.80) 0.7824 (0.75, 0.82) 0.0176 0.2905
Indirect comparison 0.7474 (0.72, 0.78) 0.8304 (0.80, 0.86) 0.0830 0.0003
Abbreviations: AUC, area under the curve; AMH, anti-M€ullerian hormone; FSH, follicle stimulation hormone; AFC, antral follicle count.
Bold indicates significance level 5 0.05
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analysis is not as successful as in conventional meta-
analysis of interventions. For intervention meta-analysis,
Song et al. [23] found that indirect comparison with adjust-
ment may be less biased than direct comparison. This
finding may not hold for indirect comparison in DTA
meta-analysis, given the different features of DTA andFig. 2. ROC curves of pairwise comparisons in direct and inintervention meta-analyses. Sometimes, people may be
too optimistic and overestimate the power of adjustment,
when we meet the problem of bias from indirect
comparison.
In this study, comparative results from direct compari-
sons are assumed as the gold standard and not biased.
But whether this assumption is valid cannot be tested.direct comparisons after covariate adjustment of age.
Table 4. Comparisons of AUCs in each pairwise comparison after covariate adjustment of age
AMH vs. FSH AMH FSH Difference P-value
Direct comparison 0.7669 (0.74, 0.79) 0.6661 (0.63, 0.70) 0.1008 !0.001
Indirect comparison 0.7374 (0.64, 0.83) 0.6095 (0.58, 0.64) 0.1279 0.0135
AFC vs. FSH AFC FSH Difference P-value
Direct comparison 0.7193 (0.69, 0.74) 0.6424 (0.61, 0.67) 0.0769 !0.001
Indirect comparison 0.7051 (0.63, 0.78) 0.6375 (0.60, 0.67) 0.0676 0.0985
AFC vs. AMH AFC AMH Difference P-value
Direct comparison 0.7207 (0.68, 0.76) 0.7332 (0.70, 0.77) 0.0125 0.4797
Indirect comparison 0.7127 (0.68, 0.75) 0.7949 (0.76, 0.83) 0.0822 0.0006
Abbreviations: AUC, area under the curve; AMH, anti-M€ullerian hormone; FSH, follicle stimulation hormone; AFC, antral follicle count.
Bold indicates significance level 5 0.05.
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certain types of diagnostic tests, such as computed tomog-
raphy and magnetic resonance imaging, which do not have
their thresholds, type I adjustments are not always feasible.
Second, in type II adjustments, the covariate effect was
considered in a linear fashion. However, the mechanism
how covariates affect test accuracy may be more complex.
Third, although we have age, BMI, and duration of subfer-
tility in this data set, there were too many missing values in
BMI and duration of subfertility. Thus, we could only use
age in type II adjustments in the analysis. It is also possible
that there is another important confounder, which is not in
our data set or even not known. Fourth, methods for doing
DTA IPD meta-analysis vary among systematic reviews
because of the different aims of the reviews and data avail-
able. Because test results in the same patients are correlated
and comparison between tests is the main interest, in this
study we used the GEE approach and paired ROC compar-
ison, which are focused on paired data. It is also possible to
compare sensitivities on certain value of specificity or vise
versa between two tests. This information can be observed
from the ROC curves. Last but not least, this study is only a
case study. Because IPD is seldom available, especially for
which comparing two or more tests and contains both direct
and indirect comparisons, we have only one data set to
perform the analysis. We believe that further research needs
to be done to investigate whether the bias can be removed if
we can adjust for all relevant covariates, which was not the
case in the current empirical study.
Unlike effect of intervention studies, in which there is al-
ways a control group or a competitor intervention, DTA
studies can only evaluate one single test against reference
standards. Although researchers always have some compar-
isons in mind, either comparing the new one with the old
one or the one from the neighbors, a competitor test is not
a must in study design [24]. In this study, we found it is diffi-
cult to get unbiased estimates from indirect comparisons,
even if with adjustment on IPD level. The differences found
between direct and indirect comparisons may lead to a
different decision in clinical practice. For example, the dif-
ference found in logit sensitivity between AMH and FSH
(Table 2) will mean that in the indirect comparisons, bothtests have more or less the same sensitivity, around 57%.
In the direct comparisons, AMH will have a higher sensi-
tivity (77%) than FSH (60%). That may mean that if one
has to decide what test to rely on more, the indirect compar-
isons may lead to a decision that it does not matter, whereas
the direct comparisons may lead to the decision of AMH be-
ing the test to rely on. The same can be seen in the compar-
ison between FSH and AFC but this time the other way
around. Although the difference is not statistically signifi-
cant, the results from the direct comparison (both tests
similar accuracy) may lead to a different decision than the
results from the indirect comparisons (AFC higher sensi-
tivity than FSH). Thus, to get a more reliable comparison
result and better evidence to support the decision, a compar-
ative study design in DTA studies is needed. Systematic re-
views will also benefit from better design of primary studies.
Comparative studies should be encouraged in DTA studies.6. Conclusion
Comparative results of test accuracy obtained through in-
direct comparisons are not always consistent with those ob-
tained through direct comparisons. Study-level covariates
were considered for adjusting the bias of indirectness, but
the adjustment did not successfully solve the problem. Sys-
tematic reviewswith IPD are considered as the gold standard,
but even with IPD, type I and type II adjustments still cannot
remove the bias of indirectness successfully. There is no
generally applicable way to make results of indirect compar-
isons more comparable to results of direct comparisons. So,
we caution that evidence from indirect comparisons should
not be combined with direct comparisons, if sufficient direct
comparisons are available. It is also an implication for re-
searches working on primary studies of diagnostic test accu-
racy: even diagnostic test can be evaluated without a
competitor, but it is still valuable to perform a comparative
study so that systematic reviewers can benefit from that.Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2014.10.005.
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